Synthesis of Minnemod: GMP Grade Apilimod For COVID-19 Clinical Trials 

Dr. Ricardo Battaglino, Professor, Vice Chair of Research, and Dr. Leslie Morse, Professor, Department Head, and Dr. Vadim Gurvich, Director of ITDD Chemical Process and Development Core, were awarded an IEM COVID-19 Rapid Response Grant. 

The grant is designed to catalyze and energize small-scale engineering research projects designed to address and mitigate COVID-19 funded by the Institute for Engineering in Medicine. Learn more about the Rehabilitation Medicine Translational Research Lab's COVID-19 clinic study with Apilimod below. 

Apilimod Clinical Trial

We expect Apilimod to be 100-times more potent than other inhibitors such as hydroxychloroquine and chloroquine that have been tested for COVID-19 treatments. - Ricardo Battaglino, PhD

Share this post

Related News